|
|
 |
|
Viewing report
|
|
|
|
Global Chiral Technology Markets
Frost & Sullivan, March 2001
New Legislative Drives Demand for Chiral Technology
Recent legislation y the U.S. Food and Drug Administration and the
European Committee for Proprietary Medicinal Products now requires pharmaceutical companies to characterize all component isomers for the drugs
they produce. Meanwhile, pharmaceutical manufacturers are increasingly out-
sourcing research, development and production to cut costs. Consequently,
the demand for chiral technology —which uses chemical, biochemical and
physical methods to produce single-isomer products —will rise significantly
over the forecast period.
This Frost &Sullivan report analyses the markets for four main types of chiral
technology, including the chiral pool, resolution technology, biocatalysts and
asymmetric synthesis. With its in-depth discussions of trends and its expert
forecasts, this research offers readers an essential guide to the future of the
field and key investment opportunities.
Need for Chiral-Based Therapeutic Drugs Boosts Market
The largest global therapeutic markets, including markets for cancer, cardiovascular and central nervous system (CNS) drugs, are increasingly turning to
chiral-based products, writes the report 's analyst. Nearly 90 percent of the
drugs for CNS dysfunction, for example, are chiral. Because of the unique
structure of chiral molecules, chiral-based drugs have superior biological activity compared with a chiral compounds and are able to treat more complex
diseases.
Greater effectiveness will mean that chiral-based products will more easily
gain patents, receive regulatory approvals and have a strong influence on the
market. This report tracks changes in key end-user markets, such as pharmaceuticals, agrochemicals and flavors and fragrances, giving your company an
important tool to formulate successful market solutions.
Universities Provide Key Strategic Partnerships
To be successful in the development of new technologies, such as asymmetric
synthesis, companies need access to innovative catalyst systems. This usually
involves in-licensing programs with major universities, as new, cutting-edge
technology is often first developed in university departments, says the author
of this report.
By in-licensing new technologies, companies can circumvent any patents
already in place and establish a worldwide exclusive right to the use of the
technology. By reviewing emerging technological developments and y recommending specific business strategies, this Frost &Sullivan report can help your
company devise an efficient, effective means of optimizing resources and maximizing market gains.
Customers who bought this item also bought
Chiral Technology - Global Strategic Business Report
Looking at Chiral Technologies
Chiral Chemicals
Chiral Technology - International Technology & Market Trends
Chiral Technology - International Technology & Market Trends
Understanding Chiral Technologies
Chiral Technologies: Commercial Opportunities of Today and the Future
Global market size for chiral drugs requiring some type of synthetic chiral chemistry in 2001, expressed as final formulation sales in dollars for each of the top nine categories and "others," with value of bulk active compounds and chiral intermedia
Chiral Separation Techniques: A Practical Approach
The 2009 Report on Chiral-Based Products: World Market Segmentation by City
New Frontiers in Asymmetric Catalysis
Neuroprotection - Drugs, Markets and Companies
|
|
|
|
